Announcements Trials

Browse Landscape

Phase

Status

Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 1 Small Cell Lung Carcinoma 1 Radiation Injuries 1 Neurotoxicity Syndromes 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1

Interventions

Carboplatin 25 Etoposide 23 Cisplatin 16 pembrolizumab 9 Topotecan 9 atezolizumab 7 Pemetrexed 7 Nivolumab 7 Radiosurgery 6 Irinotecan 5 durvalumab 4 Paclitaxel 4 Gemcitabine 4 Albumin-Bound Paclitaxel 4 rovalpituzumab tesirine 3 etoposide phosphate 3 Radiotherapy 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Cyclophosphamide 3 vistusertib 2 roniciclib 2 pelcitoclax 2 pazopanib 2 epacadostat 2 amrubicin 2 Vorinostat 2 Radiation 2 Fluorodeoxyglucose F18 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Small Cell Lung Carcinoma × Lithium × Clear all

NCT01486459 2015-03-18

TULIP

Barwon Health

Phase NA Terminated

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡